The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic Dysfunction

(2010) Gad A. Silberman et al.   CIRCULATION

Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction

(2009) Douglas S. Lee et al.   CIRCULATION

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

(2009) L. Lind et al.   EUROPEAN HEART JOURNAL

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover

(2009) Ramón Martos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography

(2009) Sherif F. Nagueh et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism

(2008) Mareike Lankeit et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prevention of Heart Failure

(2008) Douglas D. Schocken et al.   CIRCULATION

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

(2008) K. M. Eggers et al.   EUROPEAN HEART JOURNAL

State of the art: Using natriuretic peptide levels in clinical practice

(2008) Alan Maisel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure

(2008) Carlo Rostagno et al.   Internal and Emergency Medicine

Biomarkers in Heart Failure

(2008) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE